Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption

Christine L.E. Siezen1,2, Astrid I.M. van Leeuwen3, Nicolien R. Kram1, Manon E.M. Luken1, Henk J. van Kranen1 and Ellen Kampman3,4

1 Department of Toxicology Pathology and Genetics, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, 2 Department of Pathology, Josephine Nefkens Institute, Erasmus University Rotterdam, Rotterdam, The Netherlands and 3 Division of Human Nutrition, Wageningen University and Research Centre, Agrotechnion, Bomenweg 2 (bode 62), 6703 HD Wageningen, The Netherlands

4 To whom correspondence should be addressed Email: ellen.kampman{at}wur.nl


    Abstract
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 Appendix
 References
 
Associations between polymorphisms in genes (SNPs) involved in the arachidonic acid (AA) pathway and colorectal adenomas have been investigated in a Dutch case control study including 384 cases and 403 polyp-free controls. Twenty-one polymorphisms in seven candidate genes were studied and a potential modifying effect of fish consumption was considered. A protective effect on colorectal adenomas was found for the CT genotype of SNP H477H in PPAR{gamma} and the GC genotype of SNP V102V in COX-2 (OR 0.63, 95% CI 0.45–0.89 and OR 0.65, 95% CI 0.46–0.92, respectively) compared with the homozygous major genotypes. An increase in adenoma risk was observed for the TC genotype of SNP c.2242T->C in COX-2 (OR 1.47, 95% CI 1.07–2.00) compared with the TT genotype. Analysis with estimated haplotypes confirmed these associations and revealed three additional associations with COX-2, sPLA2 and 15LOX haplotypes. Fish consumption modified the associations with COX-2 and PPAR{delta} genotypes. For SNP c.-789C->T in PPAR{delta} the major genotype showed a decrease in adenoma risk for those in the highest tertile of fish consumption (T3), as compared with the lowest tertile (T1) (OR 0.65, 95% CI 0.41–1.02). Protective effects were also observed for SNPs V102V and c.2242T->C in COX-2 and high fish intake. The interaction between fish consumption and c.2242T->C was statistically significant, with an OR for the TT genotype and high fish consumption of 0.52 (95% CI 0.27–1.01) as compared with low fish intake. These results indicate that SNPs in genes involved in the AA pathway are associated with colorectal adenoma risk. Some of these associations are modified by fish consumption.

Abbreviations: AA, arachidonic acid; 95% CI, 95% confidence intervals; COX, cyclooxygenase; cPLA2, cytosolic PLA2; EPA, eicosapentaenoic acid; FAP, familial adenomatous polyposis; LOX, lipoxygenase; ORs, odds ratios; PPAR, peroxisome proliferator-activated receptor; PUFAs, polyunsaturated fatty acids; sPLA2, secretory PLA2; SNPs, single nucleotide polymorphisms; 3'-UTR, 3'-untranslated region


    Introduction
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 Appendix
 References
 
Epidemiological and experimental evidence indicates that lipid metabolism, in particular the arachidonic acid (AA) pathway, plays a critical role in colorectal tumor development, as reviewed by Jones et al. (1).

Cyclooxygenases (COX) 1 and 2, also known as prostaglandin endoperoxide synthases, are two key genes in the AA pathway, encoding enzymes that initiate the synthesis of biologically important prostanoids (PGs) and eicosanoids (2). Both genes have been demonstrated to be involved in intestinal tumorigenesis, by promoting tumor growth, angiogenesis and metastasis. Major evidence comes from the study of non-steroidal anti-inflammatory drugs, acting amongst others as COX inhibitors, which play an important role in cancer prevention (3). Inactivation of these genes in mouse models of intestinal cancer decreases the number of polyps in these mice (4,5). Phospholipases A2 are an enzyme family that, besides other conversions, catalyze the generation of free fatty acids, such as AA, from membrane bound phospholipids. Most important in the AA pathway are cytosolic phospholipase A2 (cPLA2) and secretory phospholipase A2 (sPLA2), which have both been demonstrated to be involved in tumorigenesis in mouse models (6,7). Levels of cPLA2 mRNA are reduced in mouse and human tumors, possibly indicating a tumor protective effect of this enzyme, which is further substantiated by the reduction in apoptosis in vitro after inhibiting cPLA2 (6). A similar protective effect is found for the secretory form of the enzyme, sPLA2. This gene, present at the Mom1 locus, causes an increase in the number of polyps when inactivated in the ApcMin mouse model of intestinal cancer (8). Lipoxygenase (LOX) is an enzyme for which AA is one of the substrates. Activation of the enzyme 15LOX might inhibit carcinogenesis via the conversion of linoleic acid into 13-S-hydroxyoctadecadienoic acid, which in turn down-regulates peroxisome proliferator-activated receptor (PPAR) {delta}, thereby restoring apoptosis (9). PPARs play an important regulatory role in lipid metabolism and cancer and PPARs can be activated by a variety of eicosanoids (10,11). There are three distinct types of PPARs, {alpha}, {delta} and {gamma}. Both PPAR{delta} and PPAR{gamma} have been implicated in colorectal tumorigenesis, by transcriptionally controlling pathways involved in cell proliferation, differentiation and survival. Activation of PPAR{delta} was shown to increase the number and size of intestinal polyps in ApcMin mice (12), whereas inactivation causes inhibition of tumor growth in a colorectal cancer xenograft model (13,14). Moreover, a role as a focal point of cross-talk between prostaglandin and Wnt signalling pathways has recently been suggested (15). Most data on PPAR{gamma} suggest a tumor suppressive role, however, there is still some controversy about the increase in intestinal polyps in ApcMin mice by ligands of PPAR{gamma} (16,17).

Genetic variants represented by single nucleotide polymorphisms (SNPs) in genes encoding these key players of the AA pathway may contribute to variation in susceptibility to colorectal cancer. Recently the focus of attention has shifted from the use of single (putative causal) genetic variants in association studies (the ‘direct’ approach) to using sets of genetic markers without a priori functional effects, the so-called indirect approach (18). Using information about the common SNPs in a particular population, combinations of SNP alleles called haplotypes can be estimated, after which differences in frequencies between cases and controls can be evaluated (19,20).

Colorectal adenomatous polyps, later referred to as colorectal adenomas, are presumed to be the precancerous state of colon cancer (2). Studying colorectal adenomas instead of colon cancer may give information about the risk factors in the earlier stages of carcinogenesis.

The fatty acids utilized by the AA pathway include n-3 polyunsaturated fatty acids (PUFAs) from fish. Some, but not all, animal experimental studies and epidemiological studies have shown that fish consumption may decrease the risk of colorectal tumors (21,22). A high ratio of fish fatty acids to AA in adipose tissue, as a marker for fatty acid intake, has been associated with a lower risk of colorectal adenomas (23). High fish consumption can affect the AA pathway by causing a shift in substrates from n-6 to n-3 PUFAs. SNPs in AA pathway genes may interact with fish consumption by influencing the conversion of these PUFAs into eicosanoids.

In this association study 21 SNPs in genes encoding five enzymes and two nuclear receptors have been used. The objective of this study was to assess the association between inherited SNPs and haplotypes involved in the AA pathway and the occurrence of colorectal adenomas. Moreover, the potential modifying effect of fish consumption was considered.


    Methods and materials
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 Appendix
 References
 
Study population
A retrospective case–control study was conducted in The Netherlands, between 1997 and 2001. The study design has been described in detail elsewhere (24,25). In brief, both cases and controls were undergoing endoscopy in one of eight hospitals. They were asked to participate without knowing whether they had colorectal adenomas or not. Cases and controls were Dutch speaking persons of European origin and aged between 18 and 75 years at the time of endoscopy. They did not suffer from inflammatory bowel diseases and did not have a history of colorectal cancer or (partial) bowel resection. Cases were defined as those subjects diagnosed with at least one histologically confirmed colorectal adenomatous polyp ever in their life. Controls were defined as those subjects without a history of any type of polyp, including hyperplastic and metaplastic polyps. Suspected cases of hereditary colorectal cancer syndromes were excluded (24,25).

Major indications for endoscopy among cases were complaints (47.7%), including bowel complaints, rectal bleeding and defecation problems, and screening (39.5%). For controls these numbers were 76.7% for complaints and 1.7% for screening.

Pathological anatomy reports provided information about polyp characteristics. Medical records were used for additional information on polyp recurrence and general health status of the participants.

The total study population included 925 subjects. The Medical Ethical Committees of all participating hospitals and of Wageningen University approved the study and all participants have provided written informed consent.

Genetic analysis
Twenty of the 21 SNPs were selected on the basis of an inventory of genetic variation in the Dutch population of the selected genes as described elsewhere, in which 58 polymorphisms were identified (C.Siezen, in preparation). The SNP selection was based on allele frequency (with some exceptions, only those SNPs with a minor allele frequency of 5% or higher were considered), position in the gene (when possible divided over the length of the gene), possible impact on protein function (amino acid changes) and linkage between the SNPs in one gene (of two or more tightly linked SNPs only one was selected). One SNP was selected on the basis of another population study on COX-1 variants (26).

Genotypes of the 21 SNPs were determined using a technique known as PyrosequencingTM. Each PCR contained 5 µl of 2x Hotstar master mix (Qiagen), 1 µM first primer, 0.1 µM second primer containing a so-called universal tail of 23 nt, 0.9 µM third primer with the same sequence as the tail and labeled with biotin and 10 ng genomic DNA, in a total volume of 10 µl. PCR reactions were carried out in a Perkin-Elmer 9600 thermal cycler under the following conditions: 95°C for 15 min; 40 cycles of 94°C for 45 s, 57°C for 45 s and 72°C for 1 min; 72°C for 10 min. From the biotinylated PCR products single-stranded DNAs were prepared and subsequently genotyped using a PSQ 96MA system (Pyrosequencing AB) (http://www.pyrosequencing.com) and SNP reagent kit (Pyrosequencing AB), as previously described (27). Primers for each SNP are described in the Appendix, Table AI. DNA was available from 808 participants. SNPs could not be assessed in one of these samples.


View this table:
[in this window]
[in a new window]
 
Table AI. PCR and sequencing primer sequences for each SNP

 
Fish consumption and other lifestyle factors
Information about dietary habits was obtained using a validated food frequency questionnaire (28,29). Participants were requested to recall their dietary and lifestyle habits for the year previous to their last endoscopy. Data about fish consumption was collected as number of times consumed per day, week month or year. A distinction was made between high fat fish, low fat fish and shellfish.

Information on demographic and lifestyle factors, like smoking habits, physical activity level (30) and family history, was obtained from a self-administered questionnaire.

The intake of total energy and of various nutrients was calculated from this questionnaire using the computerized Dutch food composition table.

Statistical analysis
Subjects with incomplete dietary data (n = 20) were excluded. The data analysis thus included data for 787 participants: 384 cases and 403 controls.

Logistic regression analysis was performed to calculate odds ratios (ORs) and 95% confidence intervals (95% CI) of separate genotypes when possible. If the numbers were too small, analyses were performed using pooled heterozygous and homozygous minor genotypes. The only potential confounding variables included in the model were age and gender.

Haplotypes were estimated and ORs calculated using the Hplus program, available online at http://qge.fhcrc.org/hplus. Hplus is a SNP analysis tool for performing haplotype estimations according to the distribution of genotypes in a population. It is able to handle datasets that include case–control status as well as covariates and SNP location variables (31).

Multiple logistic regression analysis was performed to evaluate the modifying effect of fish consumption. Fish consumption, in grams per day, was divided into tertiles according to the distribution of intake among controls. The lowest fish consumption tertile in combination with a homozygous major allele for the SNP of interest was considered as the reference group.

The variables age, body mass index, family history of colorectal cancer, gender, indication of endoscopy, insulin use, physical activity, education level, smoking, aspirin use, daily energy intake and intake of alcohol, calcium, fiber, fruit, red meat, poultry, processed meat, vegetables, ß-carotene, vitamin C and vitamin E were considered as potential confounding factors. Besides the variables age and gender, indication for endoscopy and alcohol consumption were also included in the model, since these factors changed the ß estimates by >10%.

To test for linear trend, we modeled the tertile of fish consumption as a continuous variable in the logistic regression model, in which each tertile was assigned its median value. To test whether the combination of genotypes and fish consumption deviated from multiplicativity, we calculated P values for interaction by inclusion of a numerical term for genotype, multiplied by fish consumption as a continuous variable, into our multivariate models. To exclude the influence of previous adenomas among cases and of undetected proximal polyps among controls, we repeated our analysis excluding these cases and controls.

The analyses were conducted using Statistical Analysis Software (SAS) for Windows, version 8.


    Results
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 Appendix
 References
 
Cases and controls were similar with respect to family history of colorectal cancer, with 22.5% of cases and 19.2% of controls having a family history of cancer. The variables age and gender differed among cases and controls. The median age for cases was 59.9 and for controls 52.2, and 53.3% of cases was male versus 38.4% of controls. However, no modifying effect was observed after stratification for age group and gender. A more detailed description of the study population characteristics was published previously (24,25). The genotypes of all SNPs studied were in Hardy–Weinberg equilibrium.

Genotypes
Table I shows the associations between genotypes and colorectal adenomas. A statistically significant inverse association was observed for the CT genotype of SNP H477H (OR 0.63, 95% CI 0.45–0.89) in the PPAR{gamma} gene as compared with the CC genotype. The OR of the TT genotype did not reach significance, but the TC and TT genotypes together also showed a statistically significant inverse association (OR 0.64, 95% CI 0.46–0.90) (data not shown) as compared with the CC genotype. For the COX-2 gene two opposite associations were observed; an inverse association for the GC genotype of SNP V102V (OR 0.65, 95% CI 0.46–0.92) and a positive association for the TC genotype of SNP c.2242T->C (OR 1.47, 95% CI 1.07–2.00) as compared with the homozygous major genotypes. In the case of both SNPs the homozygous minor genotypes did not show a statistically significant OR, but combining the heterozygous and homozygous minor genotypes resulted in a statistically significant association (OR 0.68, 95% CI 0.49–0.95 and OR 1.40, 95% CI 1.04–1.89, respectively) (data not shown), as compared with the homozygous major genotypes.


View this table:
[in this window]
[in a new window]
 
Table I. AA pathway genetic variants and colorectal adenomas

 
No statistically significant associations were observed for any of the SNPs in PPAR{delta}, COX-1, cPLA2, sPLA2 or 15LOX.

Haplotypes
Table II shows the associations between the most common haplotypes estimated and colorectal adenoma risk. The haplotypes are represented as a series of 0s and 1s, indicating for each SNP in that gene whether the major (0) or minor (1) allele is present in that haplotype. Five statistically significant associations between a specific haplotype and adenoma risk have been found. A reduction in the risk for colorectal adenomas was observed for haplotype 01 in PPAR{gamma} (C allele for P12A and T allele for H477H) and 11 in 15LOX (C allele for c.-217G->C and G allele for T485T). The ORs showed an ~50% reduction in colorectal adenoma risk (OR = 0.47 and 0.51, respectively), as compared with haplotype 00 (major alleles for both SNPs). The remaining three haplotypes showed a positive association. Haplotypes 100 and 001 in COX-2 (G alleles at position c.-1329 and amino acid 102 and the T allele for c.2242T->C and A allele at position c.-1329, G allele at amino acid 102 and C allele for c.2242T->C) showed similar ORs of 1.37 (95% CI 1.01–1.86) and 1.34 (95% CI 1.02–1.76), as compared with haplotype 000. An even greater effect was observed for haplotype 001 in sPLA2 (C allele for c.-180C->G, G allele for T32T and T allele for c.665C->T), with an OR of 2.10 (95% CI 1.11–3.95), as compared with haplotype 000.


View this table:
[in this window]
[in a new window]
 
Table II. AA pathway haplotypes and colorectal adenomas

 
Gene–diet interaction
The associations between genotypes and colorectal adenomas stratified for fish consumption are shown in Table III. There was no statistically significant association between fish consumption and colorectal adenoma risk (data not shown). A statistically significant interaction was observed between fish consumption and SNP c.-789C->T in PPAR{delta} for adenoma risk. An inverse association was observed for those with the CC genotype and highest tertile (T3) of fish consumption as compared with those with the lowest tertile (T1) of fish consumption (OR 0.65, 95% CI 0.41–1.02). However, for those with the CT or TT genotype fish consumption increased risk (T3 versus T1, CC genotype: OR 2.22, 95% CI 0.78–6.36).


View this table:
[in this window]
[in a new window]
 
Table III. AA pathway genotypes and colorectal adenomas, stratified by fish consumption

 
For COX-2 the AG and GG genotypes of SNP c.-1329A->G, located in the promoter region of COX-2, showed a positive trend towards a reduced risk of adenomas with increasing fish consumption (P = 0.01 and 0.03, respectively), as compared with those with the AA genotype and low fish consumption. Fish consumption strengthened the protective effect of SNP V102V in COX-2, to a statistically significant OR of 0.42 (95% CI 0.20–0.90) in the highest tertile of intake for individuals with the GC genotype, as compared with those with the GG genotype and low fish consumption. A statistically significant interaction was observed between fish consumption and SNP c.2242T->C, located in the 3'-untranslated region (3'-UTR) in COX-2 (P = 0.01). The homozygous major T allele was inversely associated with colorectal adenomas in the highest fish consumption tertile. Although not statistically significant, the OR of 0.52 (95% CI 0.27–1.01) reflects a reduction of almost 50% in the occurrence of colorectal adenomas, as compared with low fish consumption.

The AA genotype of SNP R651K, an A->G substitution in cPLA2, was inversely associated with colorectal adenomas for individuals in the highest fish consumption tertile (OR 0.64, 95% CI 0.41–0.96), as compared with low fish consumption. The risk of colorectal adenomas also decreased for the GG genotype of SNP c.2605G->A in cPLA2 with high consumption of fish (OR 0.59, 95% CI 0.37–0.92), as compared with low consumption of fish.

After stratification for fish consumption, no statistically significant associations were observed between genotype and adenomas for either SNP in PPAR{gamma} or for the SNPs in COX-1. There was also no effect on the associations between the genotypes of SNPs in sPLA2 and 15LOX and colorectal adenomas.

A summary of the major findings of this study is provided in Table IV.


View this table:
[in this window]
[in a new window]
 
Table IV. Summary of statistically significant results

 
All analyses were repeated for incident cases only (i.e. those with a first polyp at index endoscopy). No differences were observed in comparison with the analyses with the prevalent and incident cases together (data not shown). The same analyses were carried out for the cases with villous polyps. No marked differences were observed in comparison with the analyses with all cases, including cases with tubular and tubulovillous polyps, but the results were stronger for the cases with villous polyps (data not shown). Also, similar results were found in analyses including only subjects who underwent a full endoscopy (data not shown).


    Discussion
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 Appendix
 References
 
All AA pathway genes investigated in this study have been associated with the etiology of colorectal tumors in previous in vitro animal model and human studies. We investigated whether polymorphisms in these genes alone or in combination with fish consumption contributed to adenoma risk and found a number of statistically significant associations. The SNPs were selected with great care, however, there are SNPs with lower minor allele frequencies that could also influence colorectal adenoma risk, but because of insufficient numbers it is not feasible to evaluate these effects in this study.

The associations found between SNPs in COX-2 and colorectal polyps are supported by similar findings by Campa et al. (32), who found a positive association between the minor allele of SNP c.2242T->C in COX-2 and non-small cell lung cancer. This is not, however, in line with a previously published study in which affected siblings were tested for linkage of COX-2 variants with colon neoplasia (33). The authors suggested that genetic variation in COX-2 is unlikely to contribute to colorectal cancer risk, but, as pointed out by Ulrich and Potter (34), the population used in this study might not be representative of the general population and markers some distance away from the COX-2 locus were used. Moreover, the importance of the 3'-UTR of COX-2 is illustrated by a strong positive association between another SNP in this region and colorectal cancer observed in a study investigating a number of polymorphisms in COX-2 (35). This part of the 3'-UTR was previously thought to lie outside the gene, hence this SNP was not included in our study. In line with published data on the importance of the 3'-UTR in post-transcriptional regulation of COX-2 expression (36) it is hypothesized that SNPs in this region interfere with this process.

We found no associations between the two SNPs in COX-1 and colorectal adenomas. This is in line with two previous studies investigating one of the SNPs in COX-1 (L237M), neither of which showed a significant association (26,37). However, due to the low minor allele frequency of this SNP, false negative results cannot be ruled out.

As far as we know, H477H in PPAR{gamma} has not been tested before for colorectal tumor risk, whereas for the other variant in PPAR{gamma}, P12A, a modest protective effect of the minor allele has been found (38). This finding could not be replicated by our study, which may be explained in part by the different study populations, colorectal cancer versus adenoma patients. The involvement of this SNP in colorectal cancer development was also implicated by a study on colorectal cancer patients where the minor allele was frequently found in tumors without a K-ras mutation (39), an observation that could not be reproduced by us (data not shown). Analyzing the haplotype containing the major allele of P12A and the minor allele of H477H strengthened the association we found between H477H in PPAR{gamma} and adenomas. Moreover, the importance of specific haplotypes containing these SNPs was also illustrated by two other studies, on body weight and type 2 diabetes. However, the statistically significant association in the second study concerned the haplotype containing the minor allele of P12A and the major allele of H477H (also known as C1431T) (40,41). This does indicate, however, that there is likely a functional effect resulting from the combination of these two SNPs, either on protein function or on the amount of protein present.

We found a positive association between haplotype 001 (C allele for c.-180C->G, G allele for T32T and T allele for c.665C->T) of sPLA2 and adenomas. When the SNPs were analyzed separately no associations were apparent, illustrating again the importance of specific haplotypes. This positive association is particularly striking since the role of sPLA2 in human colorectal carcinogenesis following the discovery of the gene at the Mom1 locus (42) has been the subject of much debate. Although one study found a germline sPLA2 mutation in a sporadic colorectal cancer patient (43), there have been several other results questioning the tumor-suppressing role of human sPLA2. No somatic mutations in tumors have been found (44), neither do the differing disease phenotypes in familial adenomatous polyposis (FAP) patients correlate with sPLA2 mutations (45). Gene expression analysis revealed no change in expression levels of sPLA2 between normal mucosa and tumors (46) and an apparent lack of expression of sPLA2 was observed in colorectal cancer cell lines (47). In line with this, a study investigating the effect of single SNPs, corresponding to two of our selected SNPs (c.-180C->G and T32T), on the phenotype of FAP patients and on sporadic colorectal cancer found no associations (48). However, the effect of the third SNP (c.665C->T) and the corresponding haplotypes was not considered in that study. Our results reinforce the notion that sPLA2 is not only an important tumor suppressor in mice, but may also play a role in human tumors.

No previous studies have been reported evaluating associations between SNPs or haplotypes in the anticarcinogenic 15LOX gene and colorectal tumors. However, associations with a specific haplotype in another subtype of the LOX enzyme, the procarcinogenic 5LOX gene, have been reported recently (37), again indicating the importance of this family of enzymes in colorectal tumorigenesis.

Fish consumption can affect lipid metabolism through different mechanisms. An increase in n-3 PUFAs can lead to an increase in eicosapentaenoic acid (EPA) tissue content, and a decrease in n-6 PUFA-derived AA. This will lead to an increase in eicosanoid synthesis from EPA, resulting in a shift in production of 2-series to 3-series prostaglandins (49,50). Since prostaglandins act as ligands for PPAR{delta} (51), fish consumption may interact with PPAR{delta} by modifying the spectrum of PPAR ligands. This can be influenced by SNPs, explaining the interactions found between SNPs in PPAR{delta} and fish consumption. Besides changing the substrates and therefore the products of the AA pathway, n-3 PUFAs can also have a direct effect on the genes in the pathway. A high concentration of n-3 PUFAs has been shown to inhibit COX-2 directly, causing a decrease in the overall production of prostaglandins (52). SNPs in COX-2 might interfere with this process. Inhibition of {Delta}6-desaturase, the rate-limiting enzyme in the conversion of linoleic acid to AA, by n-3 PUFAs has also been demonstrated (53). These interactions between fish consumption, as a proxy for n-3 PUFAs, and genes in the AA pathway make it plausible that the association between SNPs in these genes and colorectal adenomas is modulated by fish consumption and, therefore, that some associations became apparent and others were strengthened, although the exact mechanisms remain far from clear.

Consideration must be given to the potential limitations of the present study, in particular the possibility of chance findings due to evaluating a large number of genes and gene–diet interactions simultaneously. Although the genes examined have been previously shown to be involved in colorectal carcinogenesis, the results of this study need to be confirmed by others.

In conclusion, this study has shown that polymorphisms in genes involved in the AA pathway may be associated with colorectal adenomas. We have shown for the first time that these associations could be modified by fish consumption, but further research to understand the mechanisms involved is needed. For example, functional studies of the SNPs implicated in this study might provide a plausible basis for the associations observed and, to minimize information bias and to assess whether n-3 fatty acids are the active agents associated with colorectal tumor risk, measurements of n-3 fatty acids in plasma samples are recommended, and are presently ongoing.


    Appendix
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 Appendix
 References
 


    Acknowledgments
 
We thank Edine Tiemersma, Elly Monster and Maria van Vugt for their important roles in the conduct of the case–control study when they were at the Division of Human Nutrition, Wageningen University and Research Centre, The Netherlands. Marga Ocke, from the National Institute of Public Health and the Environment, is thanked for providing the EPIC questionnaires and the subsequent nutrient calculations. We also thank the endoscopy staff of the following Dutch hospitals where the participants were recruited: Ziekenhuis Gelderse Vallei (Ede), Rivierenland Ziekenhuis (Tiel), University Medical Centre Nijmegen (Nijmegen), Sint Radboud (Nijmegen), Slingeland Ziekenhuis (Doetinchem), Sint Antonius Ziekenhuis (Nieuwegein), Eemland Ziekenhuis (Amersfoort), Bosch MediCentrum (Den Bosch) and Slotervaart Ziekenhuis (Amsterdam). We would like to thank Richard Laws of the Fred Hutchinson Cancer Research Center, Seattle, WA, for his help with the haplotype analysis.


    References
 Top
 Abstract
 Introduction
 Methods and materials
 Results
 Discussion
 Appendix
 References
 

  1. Jones,R., Adel-Alvarez,L.A., Alvarez,O.R., Broaddus,R. and Das,S. (2003) Arachidonic acid and colorectal carcinogenesis. Mol. Cell. Biochem., 253, 141–149.[CrossRef][ISI][Medline]
  2. Dannenberg,A.J. and Subbaramaiah,K. (2003) Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. Cancer Cell, 4, 431–436.[CrossRef][ISI][Medline]
  3. Janne,P.A. and Mayer,R.J. (2000) Chemoprevention of colorectal cancer. N. Engl. J. Med., 342, 1960–1968.[Free Full Text]
  4. Chulada,P.C., Thompson,M.B., Mahler,J.F. et al. (2000) Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res., 60, 4705–4708.[Abstract/Free Full Text]
  5. Oshima,M., Murai,N., Kargman,S., Arguello,M., Luk,P., Kwong,E., Taketo,M.M. and Evans,J.F. (2001) Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Cancer Res., 61, 1733–1740.[Abstract/Free Full Text]
  6. Dong,M., Guda,K., Nambiar,P.R., Rezaie,A., Belinsky,G.S., Lambeau,G., Giardina,C. and Rosenberg,D.W. (2003) Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis. Carcinogenesis, 24, 307–315.[Abstract/Free Full Text]
  7. MacPhee,M., Chepenik,K.P., Liddell,R.A., Nelson,K.K., Siracusa,L.D. and Buchberg,A.M. (1995) The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell, 81, 957–966.[ISI][Medline]
  8. MacPhee,M., Chepenik,K.P., Liddell,R.A., Nelson,K.K., Siracusa,L.D. and Buchberg,A.M. (1995) The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell, 81, 957–966.[ISI][Medline]
  9. Shureiqi,I., Wojno,K.J., Poore,J.A. et al. (1999) Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis, 20, 1985–1995.[Abstract/Free Full Text]
  10. Michalik,L., Desvergne,B. and Wahli,W. (2004) Peroxisome-proliferator-activated receptors and cancers: complex stories. Nature Rev. Cancer, 4, 61–70.[CrossRef][ISI][Medline]
  11. Schoonjans,K., Staels,B. and Auwerx,J. (1996) The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta, 1302, 93–109.[ISI][Medline]
  12. Gupta,R.A., Wang,D., Katkuri,S., Wang,H., Dey,S.K. and DuBois,R.N. (2004) Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth. Nature Med., 10, 245–247.[CrossRef][ISI][Medline]
  13. Barak,Y., Liao,D., He,W., Ong,E.S., Nelson,M.C., Olefsky,J.M., Boland,R. and Evans,R.M. (2002) Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity and colorectal cancer. Proc. Natl Acad. Sci. USA, 99, 303–308.[Abstract/Free Full Text]
  14. Park,B.H., Vogelstein,B. and Kinzler,K.W. (2001) Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc. Natl Acad. Sci. USA, 98, 2598–2603.[Abstract/Free Full Text]
  15. Wang,D., Wang,H., Shi,Q., Katkuri,S., Walhi,W., Desvergne,B., Das,S.K., Dey,S.K. and DuBois,R.N. (2004) Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell, 6, 285–295.[CrossRef][ISI][Medline]
  16. Girnun,G.D., Smith,W.M., Drori,S. et al. (2002) APC-dependent suppression of colon carcinogenesis by PPARgamma. Proc. Natl Acad. Sci. USA, 99, 13771–13776.[Abstract/Free Full Text]
  17. Gupta,R.A. and DuBois,R.N. (2002) Controversy: PPARgamma as a target for treatment of colorectal cancer. Am. J. Physiol. Gastrointest. Liver Physiol., 283, G266–G269.[Abstract/Free Full Text]
  18. Collins,F.S., Guyer,M.S. and Charkravarti,A. (1997) Variations on a theme: cataloging human DNA sequence variation. Science, 278, 1580–1581.[Free Full Text]
  19. (2003) The International HapMap Project. Nature, 426, 789–796.[CrossRef][ISI][Medline]
  20. Fallin,D., Cohen,A., Essioux,L., Chumakov,I., Blumenfeld,M., Cohen,D. and Schork,N.J. (2001) Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res., 11, 143–151.[Abstract/Free Full Text]
  21. Bartsch,H., Nair,J. and Owen,R.W. (1999) Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis, 20, 2209–2218.[Abstract/Free Full Text]
  22. Roynette,C.E., Calder,P.C., Dupertuis,Y.M. and Pichard,C. (2004) n-3 polyunsaturated fatty acids and colon cancer prevention. Clin. Nutr., 23, 139–151.[CrossRef][ISI][Medline]
  23. Busstra,M.C., Siezen,C.L., Grubben,M.J., van Kranen,H.J., Nagengast,F.M. and van't Veer,P. (2003) Tissue levels of fish fatty acids and risk of colorectal adenomas: a case–control study (Netherlands). Cancer Causes Control, 14, 269–276.[CrossRef][ISI][Medline]
  24. Tiemersma,E.W., Wark,P.A., Ocke,M.C., Bunschoten,A., Otten,M.H., Kok,F.J. and Kampman,E. (2003) Alcohol consumption, alcohol dehydrogenase 3 polymorphism and colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 12, 419–425.[Abstract/Free Full Text]
  25. Tiemersma,E.W., Bunschoten,A., Kok,F.J., Glatt,H., de Boer,S.Y. and Kampman,E. (2004) Effect of SULT1A1 and NAT2 genetic polymorphism on the association between cigarette smoking and colorectal adenomas. Int. J. Cancer, 108, 97–103.[CrossRef][ISI][Medline]
  26. Ulrich,C.M., Bigler,J., Sibert,J., Greene,E.A., Sparks,R., Carlson,C.S. and Potter,J.D. (2002) Cyclooxygenase 1 (COX1) polymorphisms in African-American and Caucasian populations. Hum. Mutat., 20, 409–410.
  27. Hoebee,B., Bont,L., Rietveld,E., van Oosten,M., Hodemaekers,H.M., Nagelkerke,N.J., Neijens,H.J., Kimpen,J.L. and Kimman,T.G. (2004) Influence of promoter variants of interleukin-10, interleukin-9 and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis. J. Infect. Dis., 189, 239–247.[CrossRef][ISI][Medline]
  28. Ocke,M.C., Bueno-de-Mesquita,H.B., Goddijn,H.E., Jansen,A., Pols,M.A., van Staveren,W.A. and Kromhout,D. (1997) The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire and relative validity and reproducibility for food groups. Int. J. Epidemiol., 26(suppl. 1), S37–S48.[Abstract/Free Full Text]
  29. Ocke,M.C., Bueno-de-Mesquita,H.B., Pols,M.A., Smit,H.A., van Staveren,W.A. and Kromhout,D. (1997) The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients. Int. J. Epidemiol., 26 (suppl. 1), S49–S58.[Abstract/Free Full Text]
  30. Baecke,J.A., Burema,J. and Frijters,J.E. (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr., 36, 936–942.[Abstract]
  31. Zhao,L.P., Li,S.S. and Khalid,N. (2003) A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case–control studies. Am. J. Hum. Genet., 72, 1231–1250.[CrossRef][ISI][Medline]
  32. Campa,D., Zienolddiny,S., Maggini,V., Skaug,V., Haugen,A. and Canzian,F. (2004) Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis, 25, 229–235.[Abstract/Free Full Text]
  33. Wiesner,G.L., Platzer,P., Buxbaum,S. et al. (2001) Testing for colon neoplasia susceptibility variants at the human COX2 locus. J. Natl Cancer Inst., 93, 635–639.[Abstract/Free Full Text]
  34. Ulrich,C.M. and Potter,J.D. (2001) Testing for colon neoplasia susceptibility variants at the human Cox2 locus. J. Natl Cancer Inst., 93, 1572–1574.[Free Full Text]
  35. Cox,D.G., Pontes,C., Guino,E., Navarro,M., Osorio,A., Canzian,F. and Moreno,V. (2004) Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br. J. Cancer, 91, 339–343.[ISI][Medline]
  36. Dixon,D.A., Balch,G.C., Kedersha,N., Anderson,P., Zimmerman,G.A., Beauchamp,R.D. and Prescott,S.M. (2003) Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1. J. Exp. Med., 198, 475–481.[Abstract/Free Full Text]
  37. Goodman,J.E., Bowman,E.D., Chanock,S.J., Alberg,A.J. and Harris,C.C. (2004) Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX) polymorphisms and colon cancer risk. Carcinogenesis, 25, 2467–2472.[Abstract/Free Full Text]
  38. Landi,S., Moreno,V., Gioia-Patricola,L., Guino,E., Navarro,M., de Oca,J., Capella,G. and Canzian,F. (2003) Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1 and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res., 63, 3560–3566.[Abstract/Free Full Text]
  39. Tomita,S., Kawamata,H., Imura,J., Omotehara,F., Ueda,Y. and Fujimori,T. (2002) Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene. Int. J. Mol. Med., 9, 485–488.[ISI][Medline]
  40. Doney,A., Fischer,B., Frew,D. et al. (2002) Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BioMed Central Genet., 3, 21.
  41. Evans,D., de Heer,J., Hagemann,C., Wendt,D., Wolf,A., Beisiegel,U. and Mann,W.A. (2001) Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes. Exp. Clin. Endocrinol. Diabetes, 109, 151–154.[CrossRef][ISI][Medline]
  42. MacPhee,M., Chepenik,K.P., Liddell,R.A., Nelson,K.K., Siracusa,L.D. and Buchberg,A.M. (1995) The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell, 81, 957–966.[ISI][Medline]
  43. Nimmrich,I., Friedl,W., Kruse,R., Pietsch,S., Hentsch,S., Deuter,R., Winde,G. and Muller,O. (1997) Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Hum. Genet., 100, 345–349.[CrossRef][ISI][Medline]
  44. Riggins,G.J., Markowitz,S., Wilson,J.K., Vogelstein,B. and Kinzler,K.W. (1995) Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res., 55, 5184–5186.[Abstract]
  45. Dobbie,Z., Muller,H. and Scott,R.J. (1996) Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis. Hum. Genet., 98, 386–390.[CrossRef][ISI][Medline]
  46. Dimberg,J., Samuelsson,A., Hugander,A. and Soderkvist,P. (1998) Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer. Anticancer Res., 18, 3283–3287.[ISI][Medline]
  47. Praml,C., Amler,L.C., Dihlmann,S., Finke,L.H., Schlag,P. and Schwab,M. (1998) Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa. Oncogene, 17, 2009–2012.[CrossRef][ISI][Medline]
  48. Tomlinson,I.P., Beck,N.E., Neale,K. and Bodmer,W.F. (1996) Variants at the secretory phospholipase A2 (PLA2G2A) locus: analysis of associations with familial adenomatous polyposis and sporadic colorectal tumours. Ann. Hum. Genet., 60, 369–376.[ISI][Medline]
  49. James,M.J., Gibson,R.A. and Cleland,L.G. (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr., 71, 343S–348S.[Abstract/Free Full Text]
  50. Kramer,H.J., Stevens,J., Grimminger,F. and Seeger,W. (1996) Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. Biochem. Pharmacol., 52, 1211–1217.[CrossRef][ISI][Medline]
  51. Gupta,R.A., Tan,J., Krause,W.F., Geraci,M.W., Willson,T.M., Dey,S.K. and DuBois,R.N. (2000) Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc. Natl Acad. Sci. USA, 97, 13275–13280.[Abstract/Free Full Text]
  52. Badawi,A.F., El Sohemy,A., Stephen,L.L., Ghoshal,A.K. and Archer,M.C. (1998) The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands. Carcinogenesis, 19, 905–910.[Abstract]
  53. Christiansen,E.N., Lund,J.S., Rortveit,T. and Rustan,A.C. (1991) Effect of dietary n-3 and n-6 fatty acids on fatty acid desaturation in rat liver. Biochim. Biophys. Acta, 1082, 57–62.[ISI][Medline]
Received August 26, 2004; revised November 2, 2004; accepted November 7, 2004.





This Article
Abstract
FREE Full Text (PDF)
All Versions of this Article:
26/2/449    most recent
bgh336v1
Alert me when this article is cited
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Search for citing articles in:
ISI Web of Science (1)
Request Permissions
Google Scholar
Articles by Siezen, C. L.E.
Articles by Kampman, E.
PubMed
PubMed Citation
Articles by Siezen, C. L.E.
Articles by Kampman, E.